Home › Companies › Edgewise Therapeutics, Inc. › 2024-2025

Edgewise Therapeutics, Inc. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings. Page generated 04 October 2026.

7Reported items
197Asset managers
1,345Fund votes
2025-06-13Meeting date

Proxy season: 2024-2025 2025-2026

Explore Edgewise Therapeutics, Inc. in the interactive database Compare manager voting policies

How asset managers voted at the Edgewise Therapeutics, Inc. 2024-2025 meeting

Each item below shows how the 197 asset managers that disclosed a Edgewise Therapeutics, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Edgewise Therapeutics, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. CONDUCT AN ADVISORY VOTE ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.

SECTION 14A SAY-ON-PAY VOTES

Combines 3 wordings of this item as funds reported it.

97% fund support · no official result

FOR 97%

The 191 asset managers below cast 97% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.

FOR: 97.1%AGAINST: 2.9%ABSTAIN: 0.0%NOT VOTED: 0.1%NO VOTE: 0.0%

Largest asset managers voting on “CONDUCT AN ADVISORY VOTE ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.” at Edgewise Therapeutics, Inc., 2024-2025
Asset manager	For	Against	Vote
ORBIMED ADVISORS LLC	15,245,768	0	For
RA CAPITAL MANAGEMENT, L.P.	8,275,345	0	For
BlackRock	5,366,785	15,127	For
Novo Holdings A/S	5,350,000	0	For
Janus Henderson	5,313,753	3,416	For
Paradigm Biocapital Advisors LP	5,194,713	0	For
Vanguard	4,776,562	0	For
PERCEPTIVE ADVISORS LLC	4,589,244	0	For
BRAIDWELL LP	3,587,297	0	For
Cormorant Asset Management, LP	3,572,067	0	For
Siren, L.L.C.	2,705,915	0	For
Fidelity	1,589,358	1,032,999	For
DEERFIELD MANAGEMENT COMPANY, L.P.	2,067,320	0	For
Artisan	2,001,691	0	For
First Light Asset Management, LLC	1,908,488	0	For
State Street	1,816,972	16,749	For
GEODE CAPITAL MANAGEMENT, LLC	1,750,772	0	For
Deep Track Capital, LP	1,700,000	0	For
DRIEHAUS CAPITAL MANAGEMENT LLC	1,623,972	0	For
JANUS INVESTMENT FUND	1,438,908	0	For
American Century	0	1,261,607	Against
MPM BioImpact LLC	1,171,639	0	For
Charles Schwab	1,159,413	0	For
Woodline Partners LP	1,140,008	0	For
Aberdeen	886,638	0	For

Showing the 25 largest of 191 asset managers. See all 191 in the interactive database.

2. CONDUCT AN ADVISORY VOTE ON THE FREQUENCY OF FUTURE ADVISORY VOTES ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.

SECTION 14A SAY-ON-PAY VOTES

Combines 3 wordings of this item as funds reported it.

99.9% fund support · no official result

8%ONE YEAR 48.4%1 YEAR 43%

The 188 asset managers below cast 99.9% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.

FOR: 8.0%AGAINST: 0.0%ABSTAIN: 0.0%ONE YEAR: 48.4%1 YEAR: 43.4%THREE YEARS: 0.1%NOT VOTED: 0.1%3 YEARS: 0.0%1-YEAR: 0.0%

Largest asset managers voting on “CONDUCT AN ADVISORY VOTE ON THE FREQUENCY OF FUTURE ADVISORY VOTES ON THE COMPENSATION OF OUR NAMED EXECUTIVE ” at Edgewise Therapeutics, Inc., 2024-2025
Asset manager	For	Vote
ORBIMED ADVISORS LLC	0	1 Year
RA CAPITAL MANAGEMENT, L.P.	0	One Year
BlackRock	0	1 Year
Novo Holdings A/S	0	1 Year
Janus Henderson	0	One Year
Paradigm Biocapital Advisors LP	0	One Year
Vanguard	0	One Year
PERCEPTIVE ADVISORS LLC	4,589,244	For
BRAIDWELL LP	0	One Year
Cormorant Asset Management, LP	0	1 Year
Siren, L.L.C.	0	1 Year
Fidelity	0	One Year
DEERFIELD MANAGEMENT COMPANY, L.P.	0	1 Year
Artisan	0	One Year
First Light Asset Management, LLC	1,908,488	For
State Street	0	One Year
GEODE CAPITAL MANAGEMENT, LLC	0	One Year
Deep Track Capital, LP	0	1 Year
DRIEHAUS CAPITAL MANAGEMENT LLC	0	One Year
JANUS INVESTMENT FUND	0	One Year
American Century	0	One Year
MPM BioImpact LLC	0	1 Year
Charles Schwab	0	1 Year
Woodline Partners LP	0	One Year
Aberdeen	0	One Year

Showing the 25 largest of 188 asset managers. See all 188 in the interactive database.

3. Elect the directors named in the attached Proxy Statement to serve until the 2028 Annual Meeting of Stockholders: Alan Russell, Ph.D.

DIRECTOR ELECTIONS

Combines 3 wordings of this item as funds reported it.

100% fund support · no official result

FOR 82%ABSTAIN 18%

The 64 asset managers below cast 100% of the shares they voted on this item FOR (14,071,411 for, 0 against).

FOR: 14,071,411 (82.1%)ABSTAIN: 3,060,735 (17.9%)

Largest asset managers voting on “Elect the directors named in the attached Proxy Statement to serve until the 2028 Annual Meeting of Stockholde” at Edgewise Therapeutics, Inc., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	4,610,160	0	For
BlackRock	2,864,498	0	For
Fidelity	1,589,358	514,930	For
JANUS INVESTMENT FUND	1,438,908	0	For
Artisan	856,380	0	For
American Century	0	613,417	Abstain
Charles Schwab	579,704	0	For
MUTUAL FUND SERIES TRUST	568,310	8,025	For
Aberdeen	443,319	0	For
Victory Capital	0	383,815	Abstain
DRIEHAUS MUTUAL FUNDS	0	349,368	Abstain
Federated Hermes	292,454	0	For
State Street	0	246,557	Abstain
Equitable	193,862	0	For
TIAA	193,454	0	For
Bridge Builder Trust	14,416	147,939	Abstain
QUANTITATIVE MASTER SERIES LLC	127,388	0	For
AIG/SunAmerica	0	117,285	Abstain
Lincoln Financial	0	99,997	Abstain
Jackson National	0	88,141	Abstain
Prudential/PGIM	0	74,554	Abstain
ALPS ETF Trust	0	68,275	Abstain
TRUST FOR PROFESSIONAL MANAGERS	0	64,023	Abstain
Neuberger Berman	53,283	0	For
RBB FUND, INC.	0	49,380	Abstain

Showing the 25 largest of 64 asset managers. See all 64 in the interactive database.

4. Elect the directors named in the attached Proxy Statement to serve until the 2028 Annual Meeting of Stockholders: Arlene Morris

DIRECTOR ELECTIONS

Combines 3 wordings of this item as funds reported it.

100% fund support · no official result

FOR 45.7%ABSTAIN 54.3%

The 64 asset managers below cast 100% of the shares they voted on this item FOR (7,835,400 for, 0 against).

FOR: 7,835,400 (45.7%)ABSTAIN: 9,296,746 (54.3%)

Largest asset managers voting on “Elect the directors named in the attached Proxy Statement to serve until the 2028 Annual Meeting of Stockholde” at Edgewise Therapeutics, Inc., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	4,610,160	0	For
BlackRock	0	2,864,498	Abstain
Fidelity	1,561,394	542,894	For
JANUS INVESTMENT FUND	0	1,438,908	Abstain
Artisan	856,380	0	For
American Century	0	613,417	Abstain
Charles Schwab	0	579,704	Abstain
MUTUAL FUND SERIES TRUST	568,310	8,025	For
Aberdeen	0	443,319	Abstain
Victory Capital	0	383,815	Abstain
DRIEHAUS MUTUAL FUNDS	0	349,368	Abstain
Federated Hermes	0	292,454	Abstain
State Street	0	246,557	Abstain
Equitable	0	193,862	Abstain
TIAA	193,454	0	For
Bridge Builder Trust	0	162,355	Abstain
QUANTITATIVE MASTER SERIES LLC	0	127,388	Abstain
AIG/SunAmerica	0	117,285	Abstain
Lincoln Financial	0	99,997	Abstain
Jackson National	0	88,141	Abstain
Prudential/PGIM	0	74,554	Abstain
ALPS ETF Trust	0	68,275	Abstain
TRUST FOR PROFESSIONAL MANAGERS	0	64,023	Abstain
Neuberger Berman	0	53,283	Abstain
RBB FUND, INC.	0	49,380	Abstain

Showing the 25 largest of 64 asset managers. See all 64 in the interactive database.

5. RATIFY THE SELECTION OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.

AUDIT-RELATED

100% fund support · no official result

FOR 99.9%

The 64 asset managers below cast 100% of the shares they voted on this item FOR (17,125,571 for, 0 against).

FOR: 17,125,571 (100.0%)ABSTAIN: 6,575 (0.0%)

Largest asset managers voting on “RATIFY THE SELECTION OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDI” at Edgewise Therapeutics, Inc., 2024-2025
Asset manager	For	Vote
Vanguard	4,610,160	For
BlackRock	2,864,498	For
Fidelity	2,104,288	For
JANUS INVESTMENT FUND	1,438,908	For
Artisan	856,380	For
American Century	613,417	For
Charles Schwab	579,704	For
MUTUAL FUND SERIES TRUST	576,335	For
Aberdeen	443,319	For
Victory Capital	383,815	For
DRIEHAUS MUTUAL FUNDS	349,368	For
Federated Hermes	292,454	For
State Street	246,557	For
Equitable	193,862	For
TIAA	193,454	For
Bridge Builder Trust	162,355	For
QUANTITATIVE MASTER SERIES LLC	127,388	For
AIG/SunAmerica	117,285	For
Lincoln Financial	99,997	For
Jackson National	88,141	For
Prudential/PGIM	74,554	For
ALPS ETF Trust	68,275	For
TRUST FOR PROFESSIONAL MANAGERS	64,023	For
Neuberger Berman	53,283	For
RBB FUND, INC.	49,380	For

Showing the 25 largest of 64 asset managers. See all 64 in the interactive database.

6. Advisory Vote on Say on Pay Frequency

SECTION 14A SAY-ON-PAY VOTES

— fund support · no official result

1 YEAR 78%ONE YEAR 22%

No shares were cast for or against this item by the managers below — every disclosed position was an abstention or was not voted.

1 YEAR: 221,785 (78.2%)ONE YEAR: 62,005 (21.8%)

Largest asset managers voting on “Advisory Vote on Say on Pay Frequency” at Edgewise Therapeutics, Inc., 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
Granahan Investment Management, LLC	0	0	0	0	1 Year
JPMorgan	0	0	0	0	One Year
FORUM FUNDS II	0	0	0	0	1 Year
Desjardins Global Asset Management Inc.	0	0	0	0	One Year

7. Advisory Vote to Ratify Named Executive Officers' Compensation

SECTION 14A SAY-ON-PAY VOTES

99.6% fund support · no official result

FOR 99.6%

The 4 asset managers below cast 99.6% of the shares they voted on this item FOR (282,916 for, 874 against).

FOR: 282,916 (99.7%)AGAINST: 874 (0.3%)

Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at Edgewise Therapeutics, Inc., 2024-2025
Asset manager	For	Against	Vote
Granahan Investment Management, LLC	204,643	0	For
JPMorgan	61,131	0	For
FORUM FUNDS II	17,142	0	For
Desjardins Global Asset Management Inc.	0	874	Against

Largest Edgewise Therapeutics, Inc. shareholders voting in 2024-2025

Ranked by the number of Edgewise Therapeutics, Inc. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 95,205,683 shares outstanding at the time of that meeting.

Top Edgewise Therapeutics, Inc. shareholders by shares voted, 2024-2025
#	Asset manager	% of shares outstanding
1	ORBIMED ADVISORS LLC	16.01%
2	RA CAPITAL MANAGEMENT, L.P.	8.69%
3	BlackRock	5.65%
4	Novo Holdings A/S	5.62%
5	Janus Henderson	5.58%
6	Paradigm Biocapital Advisors LP	5.46%
7	Vanguard	5.02%
8	PERCEPTIVE ADVISORS LLC	4.82%
9	BRAIDWELL LP	3.77%
10	Cormorant Asset Management, LP	3.75%

Reported Edgewise Therapeutics, Inc. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Edgewise Therapeutics, Inc. beneficial owners on record for the 2024-2025 proxy season
Holder	% outstanding	Disclosure
ORBIMED ADVISORS LLC	16.02%	13D
Baker Bros. Advisors LP	7.67%	13G
BlackRock	6.81%	13F
JANUS HENDERSON GROUP PLC	6.21%	13G
Novo Holdings A/S	5.62%	13D
Perceptive Advisors LLC	4.87%	13G
Vanguard Group	4.51%	13F
State Street	1.80%	13F
Millennium Management	0.72%	13F
Dimensional Fund Advisors	0.70%	13F

Percentages above are of 95,205,683 shares outstanding, as reported by Edgewise Therapeutics, Inc. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Edgewise Therapeutics, Inc.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At Edgewise Therapeutics, Inc.'s shareholder meeting held 2025-06-13, in the 2024-2025 proxy season, 197 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,345 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. No official Form 8-K vote tally has been matched to this meeting, so this page states no certified outcome for its most widely held ballot item. On that item — CONDUCT AN ADVISORY VOTE ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. — the reporting funds cast 97% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

Edgewise Therapeutics, Inc. proxy season coverage: 2024-2025 (this page) · 2025-2026.